August 17, 2017 7:27 PM ET


Company Overview of NaniRx Therapeutics, Inc.

Key Executives for NaniRx Therapeutics, Inc.

NameBoard RelationshipsTitleAge
There is no Key Executives data available.

NaniRx Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Peter Johann Ph.D. 40 RelationshipsNGN Capital59
David I. Cohen M.D. 8 RelationshipsMaimonides Medical Center Inc.--
H. Thomas Aretz M.D. 9 RelationshipsCaptum Capital Limited--
Martin E. Sanders M.D. 15 RelationshipsIo Therapeutics, Inc.--
Richard Granstein M.D. 8 RelationshipsWeill Cornell Graduate School of Medical Sciences--
View All Board Members

NaniRx Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
NaniRx Therapeutics, Inc. CEO Compensation
Industry Average


PsiOxus Therapeutics Announce Two New Board Members
August 17, 2017 7:00 AM ET
Isofol Medical AB (Publ) Announces Executive Changes
August 16, 2017 7:10 PM ET
Turnstone Biologics Appoints Kris Elverum as Chief Business Officer and José Manuel (Manny) Otero as Vice President, Manufacturing and CMC
August 16, 2017 12:00 PM ET
Sobi Names Trista Morrison as Vice President of Communications for North America
August 16, 2017 12:00 PM ET
Allakos Announces Management Appointments
August 15, 2017 2:01 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NaniRx Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at